Cancer prognosis using base excision repair genes.

Area of Science:

• Genomics
• Cancer Biology
• Molecular Oncology

Background:

• The base excision repair (BER) pathway is essential for maintaining genomic stability.
• Genetic factors significantly influence cancer patient responses to therapy and overall prognosis.
• BER pathway components play a critical role in cancer development and progression.

Purpose of the Study:

• To review the role of the BER pathway in advanced cancer therapies.
• To investigate the association between BER gene polymorphisms/expression and cancer outcomes.
• To explore the potential of BER as a target for cancer diagnosis and personalized treatment.

Main Methods:

• Literature review focusing on BER pathway genes (OGG1, XRCC1, APE1, Polβ).
• Analysis of studies examining polymorphisms and expression levels of key BER genes.
• Correlation of BER factor levels with cancer risk, progression, and treatment response.

Main Results:

• BER gene expression levels are closely linked to cancer risk, progression, and prognosis across various cancer types (breast, colon, lung, bladder).
• BER factors significantly affect the efficacy of chemotherapy and radiation therapy.
• Specific BER genes (OGG1, XRCC1, APE1, Polβ) show potential as predictive biomarkers.

Conclusions:

• The BER pathway is a promising target for improving cancer diagnosis and prognostic prediction.
• Targeting BER proteins could lead to the development of novel, personalized cancer therapies.
• Further large-scale prospective studies are needed to fully leverage BER pathway insights for clinical application.